EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity

Oncogene

Volumn 19, Issue 6, 2000, Pages 791-800

  Scharnhorst, Volkher ^a   Menke, Aswin L ^a   Attema, Joline ^a   Haneveld, Johan Klein ^a   Riteco, Nicole ^a   Van Steenbrugge, Gert J ^b   Van der Eb, Alex J ^a   Jochemsen, Aart G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Early growth response 1 gene product; Tumor suppression; Tumorigenesis; Wilms' tumor; Wilms' tumor 1 gene products

Indexed keywords

GROWTH FACTOR; ISOPROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MOUSE; NEPHROBLASTOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS CELL TRANSFORMATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0034628411     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203390     Document Type: Article

References (48)

1. Bernards R, Houweling A, Schrier PI, Bos JL and van der Eb AJ. (1982). Virology. 120, 422-432.
2. Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V and Hastie ND. (1992). Science, 257, 235-237.
3. Bonetta L, Kuehn SE, Huang A, Law DJ, Kalikin LM, Koi M, Reeve AE, Brownstein BH, Yeger H, Williams BR, et al. (1990). Science, 250, 940-997.
4. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, et al. (1990). Cell, 60, 509-520.
5. Cipriano SC and Chen YQ. (1998). Oncogene, 17, 1549 1556.
6. de Groot RP, Kranenburg O, de Wit L, van den Eijnden van Raaij J, Mummery C, van der Eb AJ and Zantema A. (1995). Cell Growth Differ., 6, 531-540.
7. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ and Kim SJ. (1994). Mol. Endocrinol., 8, 595-602.
8. Drummond IA, Rupprecht HD, Rohwer-Nulter P, Lopez-Guisa JM, Madden SL, Rauscher FJ and Sukhatme VP. (1994). Mol. Cell Biol., 14, 3800-3809.
9. Duarte A, Caricasole A, Graham CF and Ward A. (1998). Br. J. Cancer, 77, 253-259.
10. Eid MA, Kumar MV, lczkowski KA, Bostwick DG and Tindall DJ. (1998). Cancer Res., 58, 2461-2468.
11. Gashler A and Sukhatme VP. (1995). Prog. Nucleic Acid Res. Mol. Biol., 50, 191-224.
12. Gessler M, Konig A and Bruns GA. (1992). Genomics, 12, 807-813.
13. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM and Housman DE. (1991). Proc. Natl. Acad. Sci. USA, 88, 9618-9622.
14. Huang RP, Liu C, Fan Y, Mercola D and Adamson ED. (1995). Cancer Res., 55, 5054-5062.
15. Kinane TB, Finder JD, Kawashima A, Brown D, Abbate M, Fredericks WJ, Sukhatme VP, Rauscher FJ and Ercolani L. (1995). J. Biol. Chem., 270, 30760-30764.
16. Kinane TB, Finder JD, Kawashima A, Brown D, Abbate M, Shang C, Fredericks WJ, Rauscher FJ, Sukhatme VP and Ercolani L. (1994). J. Biol. Chem., 269, 27503-27509.
17. Lau LF and Nathans D. (1987). Proc. Natl. Acad. Sci. USA, 84, 1182-1186.
18. Lee YI and Kim SJ. (1996). DNA Cell Biol., 15, 99-104.
19. Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM and Slamon DJ. (1995). Oncogene, 11, 1261-1269.
20. Lim RW, Varnum BC and Herschman HR. (1987). Oncogene, 1, 263-270.
21. Little M and Wells C. (1997). Hum. Mutat., 9, 209-225.
22. Liu CT, Adamson E and Mercola D. (1996). Proc. Natl. Acad. Sci. USA, 93, 11831-11836.
23. Luo XN, Reddy JC, Yeyati PL, Idris AH, Hosono S, Haber DA, Licht JD and Atweh GF. (1995). Oncogene, 11, 743-750.
24. Machin GA and McCaughey WT. (1984). Histopathology. 8, 35-53.
25. Maheswaran S, Englert C, Lee SB, Ezzel RM, Settleman J and Haber DA. (1998). Oncogene, 16, 2041-2050.
26. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher 3rd FJ, Hill DE and Haber DA. (1993). Proc. Natl. Acad. Sci. USA, 90, 5100-5104.
27. McMaster ML, Gessler M, Stanbridge EJ and Weissman BE. (1995). Cell Growth Differ., 6, 1609-1617.
28. Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher 3rd FJ, van der Eb AJ and Jochemsen AG. (1996). Oncogene, 12, 537-546.
29. Menke AL, van der Eb AJ and Joehemsen AG. (1998). Int. Rev. Cytol., 18, 151-212.
30. Menke AL, van Ham RC, Sonneveld E, Shvarts A, Stanbridge EJ, Miyagawa K, van der Eb AJ and Jochemsen AG. (1995). Int. J. Cancer, 63, 76-85.
31. Millbrandt J. (1987). Science, 238, 797-799.
32. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP and Rauscher 3rd FJ. (1991). Oncogene, 6, 2339-2348.
33. Nakagama H, Heinrich G, Pelletier J and Housman DE. (1995). Mol. Cell Biol., 15, 1489-1498.
34. Rackley RR, Kessler PM, Campbell C and Williams BR. (1995). J. Urol., 154, 700-705.
35. Rauscher 3rd FJ. (1993). FASEB J., 7, 896-903.
36. Rauscher 3rd FJ, Morris JF, Tournay OE, Cook DM and Curran T. (1990). Science, 250, 1259-1262.
37. Reddy JC, Hosono S and Licht JD. (1995). J. Biol. Chem., 270, 29976-29982.
38. Royuela M, De MM, Bethencourt FR, Sanchez-Chapado M, Fraile B and Paniagua R. (1998). Growth Factors, 16, 101-110.
39. Rupprecht HD, Drummond IA, Madden SL, Rauscher FJ and Sukhatme VP. (1994). J. Biol. Chem., 269, 6198-6206.
40. Ryan G, Steele Perkins V, Morris JF, Rauscher FJ and Dressier GR. (1995). Development, 121, 867-875.
41. Scharnhorst V, Kranenburg O, van der Eb AJ and Jochemsen AG. (1997). Cell Growth Differ., 8, 133-143.
42. Slater RM and Mannens MM. (1992). Cancer Genet. Cytogenet., 61, 111-121.
43. Steegenga WT, van Laar T, Shvarts A, Terileth C, van der Eb AJ and Jochemsen AG. (1995). Virology, 212, 543-554.
44. Thigpen AE, Cala KM, Guileyardo JM, Molberg KH, McConnell JD and Russell DW. (1996). J. Urol., 155, 975-981.
45. van den Heuvel SJ, van Laar T, The I and van der Eb AJ. (1993). J. Virol., 67, 5526-5234.
46. Wang ZY, Qiu QQ, Huang J, Gurrieri M and Deuel TF. (1995). Oncogene, 10, 415-422.
47. Yew PR and Berk AJ. (1992). Nature, 357, 82-85.
48. Zantema A, Schrier PI, Davis-Olivier A, van LT, Vaessen RT and van der Eb AJ. (1985). Mol. Cell Biol., 5, 3084-3091.